Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

AbbVie Inc. buy fenjal

Start price
€69.96
09.03.19 / 50%
Target price
€81.18
20.03.19
Performance (%)
3.83%
End price
€72.64
20.03.19
Summary
This prediction ended on 20.03.19 with a price of €72.64. The BUY prediction by fenjal finished with a performance of 3.83%. fenjal has 50% into this prediction

AbbVie (ABBV) is a multinational biopharmaceutical company based in North Chicago, Illinois. It was spun off as a separate entity from Abbott Laboratories in 2013 and is primarily focused on the development and commercialization of drugs for the treatment of conditions such as immunology, oncology, and neuroscience. Its key product is Humira, which is used to treat a range of autoimmune diseases, generating a significant portion of the company's revenue. The company also has a pipeline of promising products in various stages of development, making it a reputable player in the pharmaceutical industry.

Performance without dividends (%)
Name 1w 1m 1y 3y
AbbVie Inc. 3.180% 3.180% 15.643% 87.778%
iShares Core DAX® 1.883% 5.122% 21.667% 22.437%
iShares Nasdaq 100 0.125% 2.574% 45.951% 55.507%
iShares Nikkei 225® -0.201% 4.341% 28.806% 9.945%
iShares S&P 500 0.728% 4.141% 34.630% 50.086%

Comments by fenjal for this prediction

In the thread AbbVie Inc. diskutieren
Prediction Buy
Perf. (%) 3.83%
Target price 81.180
Change
Ends at 20.03.19

fenjal stimmt dem Sentiment von 'Buy' zu

fenjal stimmt am 09.03.2019 dem Buy-Gesamtsentiment mit dem Kursziel 91.6$ zu.

Prediction Buy
Perf. (%) 3.83%
Target price 81.180
Change
Ends at 20.03.19

(Vom Mitglied beendet)

Stopped prediction by fenjal for AbbVie Inc.

AbbVie Inc.

Start price
Target price
Perf. (%)
€127.30
31.05.23
-
31.05.24
-2.20%
04.07.23

buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€136.12
20.01.23
-
20.01.24
5.42%
24.02.23

AbbVie Inc.

Start price
Target price
Perf. (%)
€148.00
12.05.22
-
12.05.23
-7.91%
02.06.22

buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€89.78
24.02.21
-
24.02.22
9.20%
07.07.21

buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€72.64
20.03.19
-
19.12.19
10.69%
19.12.19